As neratinib down-regulates HER2, HER4 and RAS, inactivates Hippo and inactivates mTOR and causes autophagosome formation, we also hypothesized repurposed neratinib could safely reduce misfolded protein levels in AD. Here, ERBB2 is linked to Alzheimer disease.